Cutaneous erythema predicted low-dose alemtuzumab response in leukemic cutaneous T-cell lymphoma

In patients with leukemic cutaneous T-cell lymphoma, diffuse cutaneous erythema without plaques or tumors predicted complete remission with low-dose alemtuzumab therapy, investigators reported online...